Company intelligence / Profile preview
JW Theriac Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
JW Theriac Pharmaceutical serves as the US-based research subsidiary of South Korea’s JW Pharmaceutical. It focuses on global open innovation and expanding an innovative new drug pipeline by leveraging proprietary platforms such as “JWELRY” and “CLOVER.” The company specializes in oncology, immunology, regenerative medicine, metabolic disease research, and collaborates with target-oriented biotech companies worldwide. Its current programs include small molecule inhibitors targeting key pathways like Wnt/β-catenin and STAT proteins; several candidates are advancing toward first-in-human studies but remain preclinical as of now.[3][4][8]
- Therapeutic areas
- OncologyMetabolic DisordersImmunologyOther
- Modalities
- Small molecules[8]Biologics[9]Cell therapies (including immune cell therapies)[6][9]New modalities (unspecified)[9]
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on JW Theriac Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JW Theriac Pharmaceutical.